Kareem joined Evelo in 2015 as vice president of business development and strategy. Prior to joining Evelo, Kareem was a director of business development at Celgene where he led a variety of licenses and collaborations, equity investments, and mergers and acquisitions. Kareem helped develop and lead Celgene’s immuno-oncology strategy that paved the way for Celgene investments, including CAR-T, checkpoint antibodies and innate immune approaches. Before this, he worked in the formulation group at Vertex where he focused on Kalydeco®, approved for the treatment of cystic fibrosis. Kareem received his B.S. in chemical engineering from Brown University and his MBA from Harvard Business School.